Vaxcyte (PCVX) Current Leases (2019 - 2026)
Vaxcyte (PCVX) reported Current Leases of $6.1 million for Q1 2026, down 0.7% year-over-year from $6.1 million in Q1 2025, and down 0.64% quarter-over-quarter from $6.1 million in Q4 2025.
Vaxcyte (PCVX) Current Leases (2019 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 7 years of Current Leases data on file, last reported at $6.1 million in Q1 2026.
- Current Leases for Q1 2026 came in at $6.1 million, down 0.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 million (down 0.7% YoY), and the FY2025 annual result was $6.1 million, up 3.96% from the prior year.
- Current Leases declined to $6.1 million in Q1 2026 per PCVX's latest filing, from $6.1 million in the prior quarter.
- Over five years, Current Leases peaked at $9.6 million in Q3 2024 and troughed at $5.8 million in Q3 2025.
- A 5-year average of $6.5 million and a median of $6.1 million in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2025: Current Leases soared 948.29% in 2022, then slumped 40.12% in 2025.
- A 5-year view of Current Leases shows it stood at $5.9 million in 2022, then grew by 20.36% to $7.1 million in 2023, then declined by 17.18% to $5.9 million in 2024, then gained by 3.96% to $6.1 million in 2025, then dropped by 0.64% to $6.1 million in 2026.
- Business Quant data shows PCVX's Current Leases at $6.1 million in Q1 2026, $6.1 million in Q4 2025, and $5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - | 6.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.09 Mn |
| Dec 31, 2025 | 6.12 Mn |
| Sep 30, 2025 | 5.77 Mn |
| Jun 30, 2025 | 6.30 Mn |
| Mar 31, 2025 | 6.13 Mn |
| Dec 31, 2024 | 5.89 Mn |
| Sep 30, 2024 | 9.64 Mn |
| Jun 30, 2024 | 7.29 Mn |
| Mar 31, 2024 | 7.20 Mn |
| Dec 31, 2023 | 7.11 Mn |
| Sep 30, 2023 | 6.03 Mn |
| Jun 30, 2023 | 5.99 Mn |
| Mar 31, 2023 | 5.95 Mn |
| Dec 31, 2022 | 5.91 Mn |
| Sep 30, 2022 | 6.43 Mn |
| Jun 30, 2022 | 6.64 Mn |
| Mar 31, 2022 | 6.58 Mn |
| Dec 31, 2021 | 5.28 Mn |
| Sep 30, 2021 | 613,000.00 |
| Jun 30, 2021 | 710,000.00 |